---
title: "Transtek: The change of medical device registration certificate for the holding subsidiary has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243424868.md"
description: "Transtek's subsidiary Ruikang Hongye has received the \"Acceptance Certificate\" from the Guangdong Provincial Drug Administration, and its application for the change of the medical device registration certificate for the dynamic electrocardiogram system has been accepted. This change aims to improve product technical requirements to meet the latest industry standards and enhance product competitiveness"
datetime: "2025-06-06T08:31:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243424868.md)
  - [en](https://longbridge.com/en/news/243424868.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243424868.md)
generator: "portal-rs"
---

# Transtek: The change of medical device registration certificate for the holding subsidiary has been accepted

Transtek announced that its holding subsidiary Ruikang Hongye recently received the "Acceptance Certificate" issued by the Guangdong Provincial Drug Administration, confirming that the application for the change of the medical device registration certificate for Ruikang Hongye has been accepted. The product being changed is the dynamic electrocardiogram system, and the application is for a change of the Class II medical device registration certificate, with the acceptance number 0010600420250551, classified as Class II, and the model specifications are G12 and G12plus. The main change is to improve the product's technical requirements according to the latest industry standards. The above matters will help the company's products further comply with the latest industry standards and enhance product competitiveness

### Related Stocks

- [300562.CN](https://longbridge.com/en/quote/300562.CN.md)

## Related News & Research

- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [Helport AI expands revenue-generating AI Labor deployments for consumer hardware customer service in North America, Europe](https://longbridge.com/en/news/296491820.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**